Eiger BioPharmaceuticals
Hepatitis treatments
Eiger BioPharmaceuticals is developer of treatments for strains of hepatitis.Homepage: http://www.eigerbio.com/
Total money raised: $7.1M
Updated on Jul 2, 2009
Eiger BioPharmaceuticals at CrunchBase
PastEiger BioPharmaceuticals at CrunchBase
Wenjin Yang VP, Chemistry
February, 2009
Eiger BioPharmaceuticals raised $7.1M in a Series A round from InterWest Partners and Vivo Ventures
Eiger snaps up $7.1M to treat hepatitis 
venturebeat.com